Literature DB >> 28254433

Loss of FKBP5 impedes adipocyte differentiation under both normoxia and hypoxic stress.

Lingling Zhang1, Bin Qiu1, Tingting Wang1, Jun Wang1, Ming Liu1, Yuxue Xu1, Chao Wang1, Ran Deng1, Kent Williams2, Zhiwei Yang1, Tiebing Liang3, Weidong Yong4.   

Abstract

FK506-binding protein 51 (FKBP51) is one of the most important regulators in the GR-mediated stress response, and we previously demonstrated that loss of FKBP5 arrests adipogenesis and renders mice resistant to diet-induced obesity (DIO). However, the exact role of FKBP5 in the process of adipocyte differentiation under hypoxic conditions (the common microenvironment where adipocytes reside in obese individuals) is still unclear. Here, by isolating and culturing WT- and Fkbp5-knockout mouse embryonic fibroblasts (MEFs), and treat them at normal oxygen environment (21% O2, nomorxia) or low oxygen environment (5% O2, hypoxia). Enhanced adipogenesis were observed at hypoxia when compared to normal oxygen environment. The loss of FKBP5 significantly prevents the adipogenesis from KO MEFs under nomorxia condition, with subtle enhancement of adipogenesis at hypoxia condition, which is similar as observed in WT-MEFs at hypoxia condition but with obvious enhancement of adipogenesis. Importantly, the protein level of FKBP5 reduced in undifferentiated MEFs under acute hypoxic stress (24 h), but drastically increased during the mid-late stage of adipocyte (Day 6) differentiation from WT-MEFs under chronic hypoxia. Furthermore, we find under normal and hypoxic conditions that FKBP5 deletion alters the expression profile of adipogenesis-related genes, including those involved in lipogenesis, lipolysis, and energy metabolism, which partially explains the compromised adipocyte differentiation in FKBP51-KO MEFs. Taken together, our findings identify a novel role of FKBP5 in hypoxia-regulated adipogenesis, and provide a candidate for anti-obesity strategies targeting FKBP51.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipogenesis; FKBP5; Glucocorticoid receptor; Hypoxic stress; Mouse embryonic fibroblasts

Mesh:

Substances:

Year:  2017        PMID: 28254433     DOI: 10.1016/j.bbrc.2017.02.126

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  The glucocorticoid receptor-FKBP51 complex contributes to fear conditioning and posttraumatic stress disorder.

Authors:  Haiyin Li; Ping Su; Terence Ky Lai; Anlong Jiang; Jing Liu; Dongxu Zhai; Charlie Tg Campbell; Frankie Hf Lee; WeiDong Yong; Suvercha Pasricha; Shupeng Li; Albert Hc Wong; Kerry J Ressler; Fang Liu
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

2.  Relation of adipose tissue and skeletal muscle FKBP5 expression with insulin sensitivity and the regulation of FKBP5 by insulin and free fatty acids.

Authors:  Marek Strączkowski; Magdalena Stefanowicz; Natalia Matulewicz; Agnieszka Nikołajuk; Monika Karczewska-Kupczewska
Journal:  Endocrine       Date:  2022-02-25       Impact factor: 3.925

3.  The deficiency of FKBP-5 inhibited hepatocellular progression by increasing the infiltration of distinct immune cells and inhibiting obesity-associated gut microbial metabolite.

Authors:  Chuantao Zhang; Xiang Cui; Lian Feng; Zhiyi Han; Deti Peng; Wenjun Fu; Yufeng Xing
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 4.  The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease.

Authors:  Gabriel R Fries; Nils C Gassen; Theo Rein
Journal:  Int J Mol Sci       Date:  2017-12-05       Impact factor: 5.923

5.  Type 2 diabetes and cardiometabolic risk may be associated with increase in DNA methylation of FKBP5.

Authors:  Robin Ortiz; Joshua J Joseph; Richard Lee; Gary S Wand; Sherita Hill Golden
Journal:  Clin Epigenetics       Date:  2018-06-19       Impact factor: 6.551

6.  Proof-of-concept for CRISPR/Cas9 gene editing in human preadipocytes: Deletion of FKBP5 and PPARG and effects on adipocyte differentiation and metabolism.

Authors:  Prasad G Kamble; Susanne Hetty; Milica Vranic; Kristina Almby; Casimiro Castillejo-López; Xesús M Abalo; Maria J Pereira; Jan W Eriksson
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

7.  Carotenoid transporter CD36 expression depends on hypoxia-inducible factor-1α in mouse soleus muscles.

Authors:  Tomoya Kitakaze; Takashi Sugihira; Hiromichi Kameyama; Asami Maruchi; Yasuyuki Kobayashi; Naoki Harada; Ryoichi Yamaji
Journal:  J Clin Biochem Nutr       Date:  2022-05-26       Impact factor: 3.179

8.  FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes.

Authors:  Cherno O Sidibeh; Maria J Pereira; Xesus M Abalo; Gretha J Boersma; Stanko Skrtic; Per Lundkvist; Petros Katsogiannos; Felix Hausch; Casimiro Castillejo-López; Jan W Eriksson
Journal:  Endocrine       Date:  2018-07-21       Impact factor: 3.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.